DENTSPLY SIRONA Inc. XRAY
9.54 USD +0.08 (+0.85%)
At closeNov 10, 2026, 6:16 AM EST
9.53 -0.01 -0.10%
Pre-market · Nov 10, 6:16 AM ET
9.32 Day range 9.62
8.14 52-week range 14.76
- YTD
- -16.54%
- 1 year
- -13.27%
News
seekingalpha.com DENTSPLY SIRONA Inc. (XRAY) Q3 2026 Earnings Call Transcript DENTSPLY SIRONA Inc. ( XRAY ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Suzanne Hatcher Daniel Scavilla - President, CEO, Interim Principal Financial Officer & Director…
benzinga.com DraftKings Posts Downbeat Q3 Results, Joins Atlassian, Natera And Other Big Stocks Moving Lower In Friday’s Pre-Market Session Stock futures mixed as DraftKings plunged 21% after earnings missed estimates and FY26 guidance was cut; several other stocks also fell premarket.
benzinga.com Dentsply Sirona Q3 2026 Earnings Call Transcript Dentsply Sirona (NASDAQ:XRAY) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
benzinga.com Dentsply Sirona Lowers FY2026 Adj EPS Guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 Est; Narrows FY2026 Sales Guidance from $3.500B-$3.600B to $3.500B vs $3.570B Est Dentsply Sirona (NASDAQ:XRAY) lowers FY2026 Adj EPS guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 analyst estimate. Narrows FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500…
benzinga.com Dentsply Sirona Q3 Adj. EPS $0.29 Misses $0.31 Estimate, Sales $836.000M Miss $862.001M Estimate Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.31 by 6.45 percent. This is a 21.62 percent decrease over earnings of…
zacks.com DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? DENTSPLY SIRONA faces Q3 earnings pressure from weak dental demand, tariff costs and segment challenges, while Wellspect's growth may offer some relief.
benzinga.com ServiceNow To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday Analysts raised targets for RS, CVLT, SLB, RNG and VEEV; cut targets for XRAY and FUN while maintaining ratings.
benzinga.com Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $13 Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $15 to $13.
benzinga.com Mizuho Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12 Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.- benzinga.com Leerink Partners Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10 Leerink Partners analyst Michael Cherny maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $14 to $10.